Key result
Higher perirenal-to-subcutaneous fat ratio is linked to ~4-fold higher odds of T2DM.
Why the study?
Differences in MSCT-measured perirenal fat thickness and perirenal-to-subcutaneous fat ratio between patients with T2DM and nondiabetic controls, and their diagnostic value for T2DM, required investigation.
Are perirenal fat thickness and perirenal-to-subcutaneous fat ratio assessed by CT independently associated with type 2 diabetes mellitus?
Cross-Sectional (n=175)
Double-blind
No
Are perirenal fat thickness and perirenal-to-subcutaneous fat ratio assessed by CT independently associated with type 2 diabetes mellitus?
Odds Ratio: 4.327 (95% CI 2.156–8.684)
p-value: p=<0.001
The CT-derived perirenal-to-subcutaneous fat ratio is a simple, reproducible imaging marker that is independently associated with type 2 diabetes and may aid in metabolic risk stratification.
Perirenal-to-subcutaneous fat ratio association with T2DM is hypothesis-generating; leaves open incremental value over standard risk markers.
This study aimed to investigate the differences in perirenal fat thickness (PRFT) and the perirenal-to-subcutaneous fat ratio (PRFT/SAFT) between patients with type 2 diabetes mellitus (T2DM) and nondiabetic controls using multislice computed tomography (MSCT) and evaluate their diagnostic value for T2DM. In this retrospective cross-sectional study, 175 participants were enrolled, including 85 patients with T2DM and 90 healthy controls matched for age, sex, and body mass index. Frequency matching was performed by stratifying all eligible subjects into age (5-year intervals) and sex strata, then randomly selecting controls from each stratum to match the case distribution. Bilateral PRFT and subcutaneous abdominal fat thickness at the umbilical level were measured on axial MSCT images. PRFT/SAFT ratios were calculated, and the differences between groups were compared. Receiver operating characteristic curve analysis was performed to assess the diagnostic performance of these parameters for T2DM. Multivariate logistic regression was used to identify independent correlates of T2DM. The mean PRFT and PRFT/SAFT ratio were significantly higher in the T2DM group than in the control group (all P < .001). Bilateral PRFT was approximately 55% higher in T2DM patients compared with controls (median: 25.6 vs 16.5 mm). No significant difference in subcutaneous abdominal fat thickness was observed between the 2 groups ( P = .433). Receiver operating characteristic analysis showed that the PRFT/SAFT ratio had the highest diagnostic efficacy for T2DM, with an area under the curve of 0.824 (95% confidence interval [CI] = 0.762–0.886), a sensitivity of 81.2%, and a specificity of 73.3% at a cutoff value of 0.89. Multivariate analysis revealed that both PRFT (odds ratio [OR] = 1.182 per 1 mm increase, 95% CI = 1.089–1.283, P < .001) and PRFT/SAFT ratio (OR = 4.327 per 1 unit increase, 95% CI = 2.156–8.684, P < .001; standardized OR = 1.52 per 1 standard deviation increase, 95% CI = 1.28–1.81) were independently associated with T2DM after adjusting for confounding factors. MSCT-measured PRFT and PRFT/SAFT ratio are significantly increased in patients with T2DM and are independent correlates of the disease. The PRFT/SAFT ratio is a simple, reproducible computed tomography-derived marker that may aid in metabolic risk stratification for T2DM, particularly in individuals with normal body mass index.
No takes yet. Share an insight, caveat, or question.
Weng et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (n=175). Perirenal-to-subcutaneous fat ratio (PRFT/SAFT) vs. Healthy controls was evaluated on Type 2 diabetes mellitus status (OR 4.327, 95% CI 2.156-8.684, p=<0.001). The perirenal-to-subcutaneous fat ratio was independently associated with type 2 diabetes mellitus, with a 1-unit increase corresponding to an odds ratio of 4.327.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: